{"url_path":"/sec/gwll/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 LEGAL PROCEEDINGS.**","topic":"sec","document":{"doc_type":"10-Q/A","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1800373/0001477932-26-004052-index.html","accession_number":"0001477932-26-004052","cik":"0001800373","ticker":"GWLL","issuer_name":"GOLDENWELL BIOTECH, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1800373/0001477932-26-004052-index.html","primary_entity_key":"0001800373","primary_entity_name":"GOLDENWELL BIOTECH, INC."},"word_count":76,"has_tables":true,"body_markdown":"**ITEM 1. LEGAL PROCEEDINGS.**\n\n \n\nThe Company is not currently subject to any legal proceedings. From time to time, the Company may become subject to litigation or proceedings in connection with its business, as either a plaintiff or defendant. There are no such pending legal proceedings to which the Company is a party that, in the opinion of management, is likely to have a material adverse effect on the Company’s business, financial condition or results of operations."}